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The cAMP responsive element-binding protein
(CREB) functions in a broad array of biological and
pathophysiological processes. We found that salt-
inducible kinase 2 (SIK2) was abundantly expressed
in neurons and suppressed CREB-mediated gene
expression after oxygen-glucose deprivation (OGD).
OGD induced the degradation of SIK2 protein
concomitantly with the dephosphorylation of the
CREB-specific coactivator transducer of regulated
CREB activity 1 (TORC1), resulting in the activation
of CREB and its downstream gene targets. Ca2+/
calmodulin-dependent protein kinase I/IV are cap-
able of phosphorylating SIK2 at Thr484, resulting in
SIK2 degradation in cortical neurons. Neuronal
survival after OGD was significantly increased in
neurons isolated from sik2/ mice, and ischemic
neuronal injury was significantly reduced in the
brains of sik2/ mice subjected to transient focal
ischemia. These findings suggest that SIK2 plays
critical roles in neuronal survival, is modulated by
CaMK I/IV, and regulates CREB via TORC1.
INTRODUCTION
Ischemic brain injury involves a complex pathophysiological
cascade that comprises many distinct pathological stressors,
including hypoxia, oxidative stress, inflammation, and glutamate
excitotoxicity (Dirnagl et al., 1999; Lo et al., 2003). A number of
molecules and compounds conferring resistance to these
stresses have been identified; however, they have failed to be
protective in clinical trials despite promising preclinical data
(Ikonomidou and Turski, 2002; Lee et al., 1999; Lo et al., 2003).
The accumulation of intracellular calcium (Ca2+) in neurons after
ischemia is a major determinant of ischemic cell death (Lo et al.,
2003). Several recent studies have suggested that some of
these limitations may be circumvented by targeting excitotoxic
signaling pathways downstream of NMDA receptors (NMDARs)106 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.(Hardingham et al., 1999, 2002; Taghibiglou et al., 2009). The
activation of NMDARs has been linked to the modulation of
a number of transcriptional factors, with either pro-survival or
pro-death activity, suggesting that the alteration of transcription
factor activity may crucially contribute to excitotoxic neuronal
injuries (Taghibiglou et al., 2009). In particular, we and others
have demonstrated that the transcription factor cAMP respon-
sive element (CRE)-binding protein (CREB) protected the brain
from ischemia mainly via its downstream neuroprotective genes
(Hardingham et al., 2002;Mabuchi et al., 2001; Peng et al., 2006).
NMDAR subtypes and localization have attracted much atten-
tion because synaptic and extrasynaptic NMDARs have been
shown to exert distinct roles in excitotoxicity (Sattler et al.,
2000). In particular, synaptic NMDARs, predominantly NR2A
receptor subtypes, and extrasynaptic NMDARs, mainly NR2B
subtypes, have opposite effects on CREB function, gene regula-
tion, and neuronal survival (Hardingham et al., 2002; Peng et al.,
2006; Liu et al., 2007). Moreover, CREB also plays a pivotal role
in an ischemic tolerance phenomenon in which brief sublethal
ischemic insults (or preconditioning) protect neurons against
a subsequent severe ischemic injury (Kitagawa, 2007; Mabuchi
et al., 2001). CREB contributes to neuroprotection by inducing
its target genes, such as brain-derived neurotrophic factor
(BDNF), peroxisome proliferator-activated receptor gamma
coactivator 1 alpha (Ppargc-1a: its product is known as PGC-1a),
and B cell lymphoma 2 (Bcl-2) (Mabuchi et al., 2001; St-Pierre
et al., 2006). In neurons, CREB-dependent gene expression
has been implicated in complex and diverse processes,
including development and plasticity (Lonze and Ginty, 2002).
The activity of CREB is regulated by phosphorylation, and
Ser133 was found to be its crucial phosphorylation site (Gonza-
lez and Montminy, 1989). Protein kinase A (PKA) is activated in
the cAMP-signaling cascade and phosphorylates CREB at
Ser133, enhancing its binding to the coactivators CREB-binding
protein (CBP) and p300 (Vo and Goodman, 2001). CBP/p300
then promote histone-chromatin remodeling through their
intrinsic histone acetyltransferase activity and recruit basal tran-
scription machinery to CRE-containing promoters (Goodman
and Smolik, 2000).
Ca2+/calmodulin-dependent protein kinase I/IV (CaMK I/IV)
are important isoforms of CaMKs in neurons and play pivotal
roles in cell survival. Indeed, CaMK IV is recognized as a key
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Role of SIK2-TORC1 in Neurotoxicitymediator of CREB-dependent cell survival in neurons because
treatment with a CaMK inhibitor renders neurons vulnerable to
ischemia concomitant with the loss of CREB phosphorylation
at Ser133 (Mabuchi et al., 2001). However, phosphorylation of
CREB at Ser133 alone is not sufficient to fully activate the
expression of target genes in peripheral tissues and the central
nervous system (CNS), suggesting that the initiation of transcrip-
tion of CREB target genes is controlled by CREB phosphoryla-
tion at Ser133 and possibly by other mechanisms (Gau et al.,
2002; Kornhauser et al., 2002).
The discovery of a family of coactivators named transducer
of regulated CREB activity (TORC, also known as CREB regu-
lated transcriptional coactivator [CRTC], with three isoforms
TORC1–3) provided new insights on CREB activation (Conkright
et al., 2003; Iourgenko et al., 2003). Under nonstimulated condi-
tions, TORC is phosphorylated and sequestered in the cyto-
plasm. Once dephosphorylated in response to Ca2+ and cAMP
signals, it translocates to the nucleus (Bittinger et al., 2004;
Screaton et al., 2004). In contrast to CBP/p300, TORC activates
transcription by targeting the basic leucine-zipper (bZIP) domain
of CREB in a phospho-Ser133-independent manner. TORC1 is
abundantly expressed in the brain and plays an important role
in hippocampal long-term potentiation at its late phase (Kova´cs
et al., 2007; Zhou et al., 2006). TORC2 is the most abundant
TORC isoform in the liver and has been found to be involved in
the gene expression of gluconeogenic programs and in the
survival of pancreatic b cells (Koo et al., 2005).
Salt-inducible kinase (SIK) was identified as an enzyme
induced in the adrenal glands of rats fed with a high-salt diet
(Wang et al., 1999). SIK isoforms (SIK1–3) belong to a family of
AMP-activated protein kinases (AMPKs). SIK1 expression is
induced by depolarization in the hippocampus and plays a role
in the development of cortical neurons through the regulation
of TORC1 (Feldman et al., 2000; Li et al., 2009). However, it
remains to be clarified whether the intracellular signaling of
SIK-TORC is crucial for CREB-dependent neuronal survival,
and if so, what acts as the upstream signaling cascade.
In the present study we found high expression levels of SIK2 in
neurons. The levels of SIK2 protein were lowered after ischemic
injury and were accompanied by the dephosphorylation of
TORC1. CaMK I/IV play an important role in the regulation of
the SIK2 degradation by phosphorylating SIK2 at Thr484. To
assess the importance of SIK2 during ischemic injury in vivo,
we generated SIK2 knockout (sik2/) mice and found that
they showed resistance to ischemic neuronal injury.
RESULTS
CREB Phosphorylation at Ser133 and CRE-Mediated
Transcription during and after Oxygen-Glucose
Deprivation in Cultured Cortical Neurons
One hour after OGD in the primary cortical cultures, CREB was
phosphorylated, and the level of phosphorylation reached
a maximum at 3–6 hr after reoxygenation, then declined to basal
levels after 12 hr post-reoxygenation (Figure 1A and S1A avail-
able online). To measure CRE activity, neurons were infected
with an adenovirus as a CRE reporter. We found a significant
enhancement of CRE activity after 3–12 hr post-reoxygenation(Figure 1B). During OGD and early (1 hr) after reoxygenation,
CREB phosphorylation was not followed by an increase in CRE
activity, but late (12 hr) after reoxygenation, CRE activity
remained high, regardless of the basal level of CREB phosphor-
ylation. The results of a reporter assay using Gal4-fusion Ser133-
disrupted CREB suggested the presence of the Ser133-inde-
pendent activation of CREB following OGD (Figure S1B).
To examine Ser133-independent regulation in cortical
neurons, we performed CRE-reporter assays in the presence
of cAMP agonists and a kinase inhibitor. Staurosporine at low
dose (10 nM), a nonspecific kinase inhibitor, decreased the level
of phospho-Ser133, but it induced the activity of a CRE reporter
to comparable levels as the phospho-Ser133-inducer db-cAMP
or forskolin (Figure S1C), suggesting the involvement of another
type of CREB coactivator, TORC.
It has been shown that CREB activity is blocked by the inhibi-
tion of calcineurin. Indeed, we found this to be true in neurons
after OGD because the calcineurin inhibitor cyclosporine A
(CsA) and FK 506 suppressed CRE activity (Figure 1C), despite
the upregulation of CREB phosphorylation by FK 506 (Fig-
ure 1C). The mechanism by which calcineurin activates CREB
could be the dephosphorylation-dependent nuclear entry of
CREB-coactivator TORCs. To examine the activity of endoge-
nous TORCs after OGD, the activity of Gal4-fusion full-length
CREB (TORC activatable) and bZIP-less CREB (TORC silent)
was monitored. The activity of the full-length CREB, but not
bZIP-less CREB, was enhanced after OGD (Figure 1D), suggest-
ing that TORCs may contribute to the Ser 133-independent
activation of CREB after OGD reoxygenation.
Dephosphorylation of TORC1 Occurs after
Reoxygenation
A high level of TORC1 protein and a moderate level of TORC2
protein were detected in primary cortical cultures (Figure S2A).
Under basal conditions, endogenous TORC1was predominantly
localized in the cytoplasm of cortical neurons (Figure 2A,
control). Although the phosphorylation levels of CREB at
Ser133 were increased during OGD (Figure S1A), TORC1 re-
mained in the cytoplasm before reoxygenation but quickly trans-
located into the nucleus after reoxygenation (Figure 2A). Indeed,
GFP-TORC1 translocated into the nucleus in response to OGD
(Figure S2B). Next, we examined the intracellular distribution
of TORC1 in response to OGD by separately isolating nuclei
from cytoplasmic compartments. OGD followed by reoxygena-
tion induced the nuclear localization of TORC1 (Figure S2C).
This process was accompanied by the dephosphorylation of
TORC1 at Ser 167 (corresponding Ser residues: Ser171
[TORC2] and Ser163 [TORC3]) (Figure 2B), followed by the
enhancement of its coactivator activity (Figure 2C). This reoxy-
genation-induced activation of TORC1 may be essential for
CREB activation because the overexpression of a dominant-
negative TORC1 (DN-TORC1, N-terminal 56 amino acids)
strongly inhibited CRE activity after OGD (Figure 2D) and aggra-
vated cell injury after OGD (Figure 2E).
To elucidate the role of TORC1 in neuronal survival, we deter-
mined the relationship between CRE activity and cell death. We
found that CRE activity in cortical neurons was enhanced by the
overexpression of TORC1, and a constitutively active TORC1Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc. 107
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Role in CRE Transcriptional Activity in
Cortical Neurons after OGD
(A) OGD-reoxygenation (in vitro ischemic model)
inducesCREBphosphorylation atSer133 (pCREB)
in a time-dependent manner. Upper panel
shows representative immunoblots of pCREB
and total CREB. Lower panel demonstrates densi-
tometric analyses of four independent experi-
ments.
(B) OGD prominently stimulates CRE-reporter
activity. Cortical neurons were cotransfected
with the adenovirus reporters Ad-CRE-fluc and
Ad-TK-rluc (an internal standard). At 48 hr postin-
fection, cells were harvested for the luciferase
assay after OGD.
(C) Inhibition of calcineurin using FK506 and CsA
upregulated CREB phosphorylation but blocked
CRE-luciferase activity at the early and late phase
after OGD. CsA and FK506 (6 hr treatment)
decreased CRE activity after OGD. Cortical neu-
rons were transiently cotransfected with the
adenovirus reporters Adeno-CRE-fluc and Adeno-
TK-rluc. Transfected neurons were subjected to
OGD in the presence or absence of FK506
(100 nmol/l) or CsA (2 mg/ml). Immunoblot analysis
of pCREB and total CREB was performed in the
presence or absence of FK506 (100 nmol/l).
(D) Primary cortical neurons were cotransfected
with Adneo-GAL4-CREB (full-length) or adeno-
GAL4-CREB bZIP-less and an Adeno-5 3 GAL4-
luciferase reporter with the internal reporter
Adeno-TK-rluc. At 48 hr postinfection, cells were
harvested for the luciferase assay after OGD.
Error bars represent ± SD; +p < 0.05; ++p < 0.01.
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Role of SIK2-TORC1 in Neurotoxicity(S167A) further upregulated CRE activity (Figure 2F). The overex-
pression of TORC1 or the TORC1S167A mutant resulted in
a significant decrease of ischemic neuronal death (Figure 2G).
The overexpression of TORC1 in cortical neurons induced the
mRNA expression of CREB-dependent pro-survival genes,
such as Ppargc-1a (PGC-1a) and BDNF (Figure 2H). In contrast,
DN-TORC1 inhibited the upregulation of these genes after OGD
(Figure S2D). Moreover, the OGD-induced reporter activity of
Ppargc-1a and bdnf promoters was impaired by mutating their
CREs (Figure S2E), suggesting that TORC1-CREB may actively
determine neuronal survival after ischemia.
Suppression of SIK2 Enhances Neuronal Survival
after OGD
TORC family coactivators are phosphorylated by SIK1, SIK2,
and AMPK (Katoh et al., 2006; Koo et al., 2005; Screaton et al.,
2004; Takemori andOkamoto, 2008), and quantitative PCR anal-
yses suggest a high level of SIK1 and SIK2 mRNA in the cortex
(Figure S3A). We found that SIK2 protein was expressed in the
hippocampus and cortex (Figures S3B and S3C) and was abun-
dant in nonstimulated neurons (Figure S3D); however, SIK1
protein was not detected in these cells (data not shown) with
a highly purified anti-SIK1 antibody (Uebi et al., 2010). Next,
we examined the involvement of these kinases in the regulation
of TORC1 after OGD in cortical neurons (Figure 3A). The level of108 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.SIK1 remained low during and after OGD. The level of pAMPK
increased during OGD but quickly returned to the basal level
after reoxygenation. In contrast the level of SIK2 decreased in
an early phase of reoxygenation (3 hr), and it was maintained
at a low level until 24 hr post-reoxygenation, suggesting that
this downregulation of SIK2 may be important for the activation
of TORC1-CREB after reoxygenation. Therefore, we next deter-
mined the contribution of SIK2 to the regulation of TORC1 in
cortical neurons.
To elucidate the importance of SIK2, we tried to identify small
compounds that could inhibit SIK2 activity more selectively than
staurosporine. Fortunately, by the use of a small kinase-inhibitor
library, we identified Compound C, a potent inhibitor of AMPK,
as a SIK2 inhibitor (Figure S3E). The effective dose of Compound
C against SIK2 in cultured cells was 10-fold lower than that
against SIK1 or AMPK (Figures S3F and S3G). The IC50 of
Compound C for the SIK2-dependent suppression of forskolin-
induced CRE activity was approximately 0.3 mM, whereas the
concentration required to inhibit the AMPK-mediated phosphor-
ylation of acetyl-CoA carboxylase (ACC) was greater than 3 mM
(Figure S3G). The dose response of Compound C suggested
that 0.1–1.0 mM would enable us to distinguish its effect on
SIK2 from its effects on SIK1 or AMPK. Indeed, 0.3–0.5 mM of
Compound C upregulated CRE activity in cultured neurons after
OGD (Figure S3H) and reduced neuronal death (Figure S3I). On
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Figure 2. Activation of Neuronal TORC1
Prevents Neuronal Death after OGD
(A) Endogenous TORC1 protein staining by immu-
nofluorescence analysis in cortical neurons under
basal conditions and following OGD. The insets in
the bottom panels showed higher magnification of
TORC1/MAP2 in cells indicated with arrows. Scale
bar, 25 mm.
(B) Western blot analysis of TORC1 protein and
TORC1 phospho-Ser167 from primary cortical
neurons at the indicated periods following OGD.
(C) Primary cortical neurons were cotransfected
with adeno-GAL4-fusion TORC1 and the Adeno-
5 3 GAL4-luciferase reporter with the internal
reporter Adeno-TK-rluc. The specific transfection
activities of TORC1 were expressed as the fold
activation of the empty adeno-GAL4 vector pM.
(D) Primary cortical neurons were cotransfected
withadenovirusesexpressingEGFPorDN-TORC1,
and adenovirus CRE reporters.
(E) The LDH assay was performed using adeno-
EGFP- or adeno-DN-TORC1-transfected primary
cortical neurons subjected to OGD for 2 hr and
reoxygenation for 24 hr (+p < 0.05 compared
with EGFP groups; n = 10).
(F) Transient assay showing the effect of wild-type
or S167A mutant TORC1 on CRE-luc reporter
activity in cortical neurons exposed to OGD.
Data are representative of at least four indepen-
dent experiments.
(G) The LDH assay was performed using adeno-
EGFP, adeno-TORC1, or adeno-TORC1 S167A-
transfected primary cortical neurons subjected
to OGD for 3 hr and reoxygenation for 24 hr
(#,+p < 0.05 compared with EGFP groups; n = 14).
(H) Real-time RT-PCR analysis of PGC-1a and
BDNF mRNA expression as a ratio of b-actin
mRNA expression in adeno-EGFP or adeno-
TORC1-transfected primary cortical neurons. A
significant upregulation in Ppargc-1a and BDNF
mRNA expression was observed for adeno-
TORC1-transfected primary cortical neurons.
Error bars represent ± SD; #,+p < 0.05;
##,++p < 0.01.
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Role of SIK2-TORC1 in Neurotoxicitythe other hand, we demonstrated that Compound C, at the dose
used for AMPK inhibition (>3 mM), was toxic to cortical neurons
after OGD (Figure S3I). These findings suggested that SIK2 could
have a greater effect on TORC1-CREB activity than SIK1 or
AMPK.
The overexpression of SIK2 and its constitutively active form
(S587A) strongly inhibited CRE activity after OGD (Figure 3B),
whereas the kinase-defective SIK2 (K49M) failed to suppress
CRE activity. In agreement with the CRE-reporter assay, the
overexpression of S587A increased cell death, whereas K49M
decreased cell death after OGD (Figure 3C). Furthermore, the
overexpression of the S587A mutant SIK2 resulted in a substan-
tial amount of TORC1 in the cytoplasm after OGD (Figure 3D).
The overexpression of SIK2 also suppressed the TORC1-depen-
dent activation of CRE, and SIK-resistant TORC1 (S167A)
blocked this suppression (Figure 3E).
When SIK2 was knocked down using SIK2-specific microRNA
(miRNA) (Figure 3F), CRE activity was relatively enhanced in thelate phase after OGD (after 12 hr; Figure 3G). The knockdown of
SIK2 also attenuated neuronal death after OGD (Figure 3H).
Although overexpression of TORC1 did not confer an additional
protective effect under SIK2 downregulation, the overexpression
of DN-TORC1 abolished the protective effect of SIK2-specific
miRNA (Figure 3H). These findings suggested that SIK2 plays
an essential role in neuronal survival after OGD via a TORC1-
dependent pathway.
CaMK I/IV Is an Upstream Regulator of TORC1 Signaling
in Neurons
To determine which kinase cascades mediate the activation of
CRE-dependent transcription, we pretreated cortical neurons
with various kinase inhibitors and found that KN93, a CaMK
II/IV inhibitor, blocked CRE-mediated transcription after OGD
(Figure 4A). Gal4-fusion TORC1 activity was also inhibited by
KN93 (Figure 4B), and KN-93 also blocked the decrease in the
levels of SIK2 protein after OGD (Figure S4A).Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc. 109
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Figure 3. SIK2 Is an Important Molecular Regulator of Ischemic Neuronal Injury
(A) Western blot analysis of SIK2, SIK1, pAMPK, and AMPK from cortical neurons at the indicated periods following OGD.
(B) CRE activity in cortical neurons transfected with wild-type, kinase-inactive (K49M), PKA phosphorylation-defective (S587A) SIK2, or LacZ-expressing adeno-
viruses at the early (3 hr) or delayed phase (12 hr) after OGD.
(C) The LDH assay was performed using LacZ, K49M, or S587A SIK2-transfected cortical neurons subjected to OGD (n = 12).
(D) Effect of constitutively active (S587A) SIK2 on the subcellular localization of TORC1 after OGD. An immunofluorescence assay of endogenous TORC1 in
cortical neurons is shown. Scale bar, 25 mm.
(E) Transient assay of cortical neurons cotransfected with wild-type SIK2, and either wild-type- or S167A-TORC1-expressing viruses. A fixed amount of either
wild-type- or S167A-TORC1-expressing viruses and escalating amounts of SIK2-expressing viruses were used. Luciferase activity from adeno-CRE reporters is
shown.
(F) Knockdown of SIK2 with SIK2-specific miRNA in primary cortical neurons.
(G) Knockdown of SIK2 with miRNA leads to enhanced CRE activity after OGD. Primary cortical neurons were cotransfected with LacZ- or SIK2-specific miRNAi-
expressing adenoviruses and CRE reporters. At 4 days postinfection, cells were harvested for the luciferase assay after OGD.
(H) LDH assay after transfection with LacZ- or SIK2-specific miRNAi-expressing adenoviruses after OGD (n = 12). Additionally, the LDH assay was performed
under conditions of SIK2 knockdown by using SIK2 miRNA in combination with the overexpression of adeno-EGFP, adeno-TORC1, or adeno-DN-TORC1.
Error bars represent ± SD; #,+p < 0.05.
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Role of SIK2-TORC1 in NeurotoxicityTo identify the specific isoform of CaMK that is implicated in
TORC-CREB-dependent transcription, dominant-active forms
of CaMKs (DA-CaMK I; dominant-active CaMK I [catalytic
domain], DA-CaMK IIA [catalytic domain], and DA-CaMK IV
[full-length protein without its auto-inhibitory domain]) were
expressed in Gal4-fusion reporter systems (Figure 4C). The
activity of TORC-responsive CREB and TORC-non-responsive110 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.CREB (Gal4-CREB bZIP-less) were upregulated by the overex-
pression of CaMK I and IV, but not by CaMK IIA. In addition to
CREB, CaMK I and IV upregulate TORC1 activity (Figure 4C).
Conversely, DN (dominant negative; kinase-dead form)-CaMK I
(K49E) and DN-CaMK IV (K75E) blocked TORC1-mediated
transcriptional activity after OGD (Figure 4D) and SIK2 degra-
dation after OGD (Figure S4B). Also, the overexpression of
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Figure 4. CaMK I/IV Regulate the SIK2-
TORC1 Cascade
(A) The screening of protein kinase inhibitors that
inhibit CRE-dependent transcription after OGD.
Cortical neurons were transfected with the
Ad-CRE-fluc reporter and Ad-TK-rluc (an internal
standard). At 48 hr later, cells were treated
with KT5720, KN93, U0126, LY294002, or DMSO
for 6 hr, and then subjected to OGD and reoxyge-
nation.
(B) CaMK is responsible for TORC1 activity in
cortical neurons. Primary cortical neurons were
cotransfected with adeno-GAL4-fusion TORC1
and the Adeno-5 3 GAL4-luciferase reporter with
the internal reporter Adeno-TK-rluc. The specific
transfection activity of TORC1 was expressed as
the fold activation of the empty adeno-GAL4
vector pM.
(C) Primary cortical neurons were cotransfected
with either the EGFP-, DA-CaMK I-, DA-CaMK
IIA-, or DA-CaMK IV-expressing adenoviruses,
and Adeno-GAL4-CREB (full length) (left), Adeno-
GAL4-CREB bZIP-less (middle), or Adeno-GAL4-
TORC1 (right) and the Adeno-53GAL4-luciferase
reporter with Adeno-TK-rluc.
(D) TORC1 activity in cortical neurons transfected
with DN-CaMK I- (K49E), DN-CaMK IV- (K75E), or
EGFP-expressing adenoviruses at the early (3 hr)
or delayed phase (12 hr) after OGD.
(E) Primary cortical neurons were transfected with
DA-CaMK IV-expressing adenoviruses relative to
LacZ-expressing adenoviruses, and an LDH assay
was performed after OGD.
Error bars represent ± SD; +p < 0.05; ++p < 0.01.
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Role of SIK2-TORC1 in NeurotoxicityDN-TORC1 resulted in a significant reduction in CRE activity that
was enhanced by CaMK I or CaMK IV in cortical neurons under
control conditions and after OGD (Figure S4C). This finding sug-
gested that CaMK I and IV may be able to activate CREB (via
phosphorylation at Ser133) and TORC.
Endogenous CaMK IV is predominantly restricted to the
nucleus, whereas overexpressed CaMK IV was localized in
both the cytoplasm and nucleus (Figure S4D). To determine
the role of endogenous CaMK IV, we confirmed its involvement
in the regulation of OGD-induced TORC activation by means
of RNA interference (RNAi) experiments. Treatment with rat
CaMK IV-specific miRNA decreased the level of CaMK IV, not
CaMKI (Figure S4E). We found that the knockdown of CaMK IV
resulted in the inhibition of TORC1 activity (Figure S4F) and
aggravated cell injury after OGD (Figure S4G). Furthermore,
transfection of human CaMK IV, which is resistant to miRNA
for rat CaMK IV, reversed the CaMK IV protein level and attenu-Neuron 69, 106–119,ated the cell injury by CaMK IV knock-
down (Figures S4E and S4G). These
results suggested that CaMK IV may
upregulate CRE-mediated transcription
in a CREB Ser133- and TORC1-depen-
dent manner. Indeed, the overexpression
of DA-CaMK IV significantly decreased
neuronal injury after OGD (Figure 4E).On the basis of these findings, CaMK I and CaMK IV were iden-
tified as negative regulators of SIK2.
Synaptic NMDAR Activity Induces TORC1 Activity
via CaMK-SIK2 Signaling
CaMK I and IV are activated by binding elevated Ca2+ levels
to calmodulin, Ca2+/calmodulin, and Ca2+ influx, principally
through NMDARs, activated cytoplasmic, and nuclear CaMKs.
However, it was reported that different subtypes of glutamate
receptors have opposite actions on neuronal survival (Hardi-
ngham et al., 2002; Liu et al., 2007; Peng et al., 2006). To deter-
mine the involvement of different types of glutamate receptors
on TORC1-mediated transcriptional activity after OGD, we
administered several types of glutamate receptor antagonists.
Treatment with either an NMDAR antagonist, AP5, or an
NR2A antagonist, NVP-AM0077, attenuated OGD-induced
TORC1 activity. In contrast, other types of glutamate receptorJanuary 13, 2011 ª2011 Elsevier Inc. 111
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Figure 5. Activation of the NR2A-Contain-
ing NMDAR Induces TORC1 Activity via
CaMK-SIK2 Signaling
(A) Screening different types of glutamate receptor
antagonists that inhibit TORC1-dependent tran-
scription after OGD. Cortical neurons were trans-
fected with adeno-GAL4-fusion TORC1 and the
Adeno-5 3 GAL4-luciferase reporter with the
internal reporter Adeno-TK-rluc. At 48 hr later, cells
were treated with CNQX, nifedipine, AP5, NVP-
AAM0077 (NR2A-specific antagonist), Ro25-6981
(NR2B-specific antagonist), or DMSO for 2 hr,
and then subjected to OGD and reoxygenation.
(B) Endogenous TORC1 protein localization by
immunofluorescence analysis in cortical neurons
following OGD. Treatment with NVP-AAM0077
blocked the nuclear localization of TORC1 after
OGD. Scale bar, 15 mm.
(C) NVP-AAM0077 treatment blunted the SIK2
degradation after OGD.
(D) Synaptic activation by treatment with Bic and
4-AP resulted in the degradation of SIK2 protein.
(E) Administration of Bic and 4-AP induced the
nuclear localization of TORC1. The neurons were
lysed using IP-lysis buffer supplemented with
0.1% Triton X-100. The nucleic and cytoplasmic
fractions were separated by centrifugation at
3000 rpm for 5 min.
(F) Synaptic activity contributed to TORC1 activity
in cortical neurons. Primary cortical neurons
were cotransfected with adeno-GAL4-fusion
TORC1 and the Adeno-5 3 GAL4-luciferase
reporter with the internal reporter Adeno-TK-rluc.
The specific transfection activity of TORC1 was
expressed as the fold activation of the empty
adeno-GAL4 vector pM.
Error bars represent ± SD; +p < 0.05.
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Role of SIK2-TORC1 in Neurotoxicityantagonists such as CNQX, L-type Ca2+ channel blocker,
nifedipine, or the NR2B-containing NMDAR-specific inhibitor
Ro25-6981 did not show any effect on TORC1-mediated tran-
scriptional activity (Figure 5A). Treatment with NVP-AAM0077
inhibited the nuclear localization of TORC1 (Figure 5B) and
SIK2 degradation after OGD (Figure 5C). Although the subunit
specificity of NVP-AAM0077 is debated (Neyton and Paoletti,
2006), these findings suggested that the activation of NR2A-con-
taining NMDARs results in the degradation of SIK2 following
CaMK I/IV activation, leading to enhanced TORC1 activity after
OGD. Next, to determine whether stimulation of NR2A-contain-
ing NMDARs leads to the activation of the SIK2-TORC1-CREB
cascade, we treated neurons with bicuculline (Bic) and 4-amino-
pyridine (4-AP), which have been shown to stimulate neuronal
synapses and activate NR2A receptors (Hardingham et al.,112 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.1999, 2002; Taghibiglou et al., 2009).
When cortical neurons were treated with
the Bic and 4-AP, SIK2 protein levels
were decreased (Figure 5D), and subse-
quently led to the nuclear localization of
TORC1 (Figure 5E) and the increase of
TORC1-mediated transcriptional activity
(Figure 5F). On the other hand, whenneurons were treated with the NR2A-specific antagonist, NVP-
AAM0077, together with Bic and 4-AP, SIK2 degradation was
blocked (Figure S5A) and was followed by a decrease in the acti-
vation of TORC1-mediated transcriptional activity (Figure S5B).
DN-CaMK I (K49E) and IV (K75E) blocked the TORC1-mediated
transcriptional activity induced by Bic and 4-AP (Figure S5C).
Furthermore, DN-TORC1 inhibited CRE activity after the treat-
ment with Bic and 4-AP (Figure S5D).
Destabilization of SIK2 by CaMK I/IV-Mediated
Phosphorylation at Thr 484
We then examined whether the Ca2+/CaMK I/IV pathway could
reduce the level of SIK2 protein after OGD (shown in Figure 3A).
A decrease in the level of protein is often the result of protein
degradation via the proteasome, and the proteasomal inhibitor
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Figure 6. SIK2 Thr484 Phosphorylation Is Mediated through CaMK I/IV
(A) The proteasome inhibitor lactacystin (10 mM) reduced the degradation of SIK2 after OGD.
(B) Cortical neurons were transfected with EGFP-, DA-CaMK I-, DA-CaMK IIA-, or DA-CaMK IV-expressing adenoviruses. After 72-hr incubation, cells were sub-
jected to immunoprecipitation (IP) using anti-SIK2 sera followed by western blot analysis with anti-SIK2 Ser587- and Thr484-specific antibodies.
(C) Amino acid alignments of the phosphorylation motif of mammalian SIK2 by CaMK I/IV.
(D) An in vitro kinase assay of active CaMK I and IV with the substrate GST-SIK2 peptide (Thr 484) in the presence or absence of ATP. Phosphorylation signals
were detect by western blot with anti-phospho-Thr 484, and total substrate was stained with Coomassie brilliant blue (CBB).
(E) The phosphorylation of SIK2 Thr484, not Ser587, occurs prior to the degradation of SIK2 in cortical neurons after OGD. Primary cortical neurons were
harvested after the indicated periods following OGD. Cells were subjected to immunoprecipitation (IP) using anti-SIK2 sera followed by western blotting using
Ser587- or Thr484-specific antibodies.
(F) Neurons were cotransfected with LacZ- or T484A-SIK2-expressing adenoviruses, and the cells were exposed to OGD-reoxygenation after 48 hr. The immu-
nofluorescent localization of endogenous TORC1 was examined. Scale bar, 25 mm.
(G) Cortical neurons were cotransfected with T484A SIK2- or EGFP-expressing adenoviruses, and Ad-CRE-fLuc and Ad-TK-rLuc. CRE activity was measured at
the early (3 hr) or late phase (12 hr) after OGD.
(H) Neurons were transfected with wild-type- or T484A-SIK2, and SIK2 protein levels were monitored by using immunoblotting after OGD. b-Actin was used as
a loading control.
Error bars represent ± SD; +p < 0.05.
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Role of SIK2-TORC1 in Neurotoxicitylactacystin has been shown to stabilize SIK1 and SIK2 (Katoh
et al., 2006; Takemori and Okamoto, 2008). Thus, we treated
the cells with lactacystin and found that the inhibitor blocked
the decrease of SIK2 protein levels in cells subjected to OGD
(Figure 6A). cAMP-PKA phosphorylates SIK2 at Ser587 and
downregulates TORC-phosphorylation activity of SIK2, but it
does not change its protein level (Katoh et al., 2006; Takemori
and Okamoto, 2008). On the other hand, the overexpression ofCaMK I/IV decreased SIK2 protein levels (bottom panel in Fig-
ure 6B). Also, a Ser587 residue in the C-terminal regulatory
domain of SIK2 is autophosphorylated and negatively regulates
its TORC-phosphorylation activity (Katoh et al., 2006; Takemori
and Okamoto, 2008). Because the S587A mutant negatively
regulates CRE activity (Figure 3B), we examined the involvement
of Ser587 phosphorylation in SIK2 degradation. However,
the level of Ser587 phosphorylation was almost similar in cellsNeuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc. 113
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Role of SIK2-TORC1 in Neurotoxicityoverexpressing DA-CaMK I and IV compared to GFP-expressing
cells (middle panel in Figure 6B). Therefore, we decided to iden-
tify the other CaMK phosphorylation sites in SIK2 that contained
the CaMK motif R/K-X-X-S/T (White et al., 1998) by lining up the
domains that are conserved from insects to vertebrates. We
found that Thr484 is a candidate site for CaMK-mediated phos-
phorylation (Figure 6C). Indeed, a specific antibody against
phospho-Thr484 revealed enhanced Thr484 phosphorylation in
neurons overexpressing DA-CaMK I and IV (upper panel in
Figure 6B).
To further examine whether CaMK could directly phosphory-
late SIK2 at Thr484, we performed an in vitro kinase assay.
The in vitro kinase assay using a GST-fusion Thr484-peptide
(GQRRHT484LSEVT) provided evidence that Thr484 is a good
substrate for CaMK I and IV (Figure 6D). Time course experi-
ments clearly showed that the level of phosphorylation at
Thr484, but not at Ser587, was elevated after OGD (Figure 6E).
The overexpression of CaMK I or IV partially inhibited the
suppression of CRE activity induced by wild-type SIK2 but had
no effect on the CaMK-resistant SIK2 mutant T484A (Figure S6).
The SIK2 T484A mutant blocked the nuclear entry of TORC1
(Figure 6F) and CRE activity (Figure 6G) in cortical neurons sub-
jected to OGD. Moreover, the decrease in SIK2 protein levels
after OGD-reoxygenation was inhibited in neurons overexpress-
ing the SIK2 T484Amutant compared to neurons overexpressing
wild-type SIK2 (Figure 6H). On the basis of these findings, we
suggest that the phosphorylation of SIK2 at Thr484 occurs prior
to and may be necessary for the degradation of SIK2 in cortical
neurons.
Enhanced Neuronal Survival after OGD in sik2
Knockout Mice
The data from primary cortical neurons indicated that SIK2 plays
a key role in mediating neuronal protection by regulating gene
expression through CREB-TORC1 signaling. To further elucidate
the role of SIK2 in vivo, we generated mice with a deletion of the
sik2 gene (Figures S7A and S7B). These Sik2/mice apparently
had no phenotype for body weight control, whereas the mice
facilitated eumelanin (blackmelanin) synthesis in their hair follicle
melanocytes (Horike et al., 2010). When we prepared primary
cortical cultures from wild-type and sik2/mice, and subjected
them to reporter assays, we found enhanced CRE activity (Fig-
ure 7A) and TORC1 coactivator activity (Figure 7B) in neurons
derived from sik2/ mice after OGD compared with wild-type
mice. After OGD the number of surviving neurons isolated from
sik2/ mice was much higher than from wild-type mice (Fig-
ure 7C). To confirm that such protection from ischemic brain
injury was due to sik2 deficiency, re-expression experiments
were performed by transfecting SIK2/ neurons with SIK2 (Fig-
ure S7C). Transfection of SIK2 in SIK2/ neurons decreased
CRE activity and increased ischemic neuronal injury compared
with neurons that were transfected with EGFP. In addition,
high levels of promoter activity for Ppargc-1a, BDNF, and
Trk-B were observed in sik2/ neurons after OGD (Figure 7D).
These results suggested that SIK2 knockdown promotes the
neuroprotective program by upregulating TORC-CREB activity
followed by the increased expression of neuroprotective CREB
target genes.114 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.SIK2 Knockout Mice Are More Resistant to Focal
Cerebral Ischemia
To investigate the role of SIK2 on neuroprotection in vivo, mice
were subjected to 60-min middle cerebral artery occlusion
(MCAO) followed by 48 hr reperfusion. We assessed the intracel-
lular distribution of TORC1 and SIK2 proteins after MCAO (Fig-
ure S8). Similar to the in vitro experiments, ischemia triggered
the nuclear translocation of TORC1 (Figures S8A and S8B)
and the degradation of SIK2 in the ischemic cortex after
MCAO (Figure S8C). In contrast, SIK1 levels remained low after
MCAO (Figure S8C). In line with the findings of in vitro OGD,
we observed that the level of Thr484 phosphorylation of SIK2
increased after MCAO (Figure S8D). Next, to investigate the
effect of SIK2 deficiency on neuroprotection, wild-type and
sik2/ mice were subjected to 60-min MCAO followed by
48-hr reperfusion. We found no differences in their basal physi-
ological parameters, including rectal temperature, brain skull
temperature, and mean arterial blood pressure. Residual cere-
bral blood flow in the ischemic hemisphere was comparable in
sik2/ and wild-type mice at all time points during and after
ischemia (data not shown). In wild-type mice, we observed no
significant difference in the phosphorylation levels of TORC1 at
Ser167 between the ipsilateral and contralateral regions at
24 hr after MCAO (Figure 8A); however, in SIK2 null mice there
was a 50% reduction in the phosphorylation level of TORC1 (Fig-
ure 8A). Therewere no significant differences in the expression of
SIK1 and SIK3 betweenwild-type and SIK2 null mice, suggesting
no compensatory upregulation of SIK1 or SIK3 expression in
SIK2 null mice (Figure S7D). Importantly, ischemic lesions after
MCA occlusion were markedly smaller in SIK2 null mice (27.2 ±
5.8 mm3) than in wild-type mice (69.1 ± 6.1 mm3) (Figures 8B
and 8C).
We suspected that several key genes contributed to the
neuronal protection observed following SIK2 deletion. To
address this point, quantitative RT-PCR of cerebral cortex sub-
jected to MCAO or sham operation was used to examine the
levels of previously identified CREB target genes and other
CREB-independent genes in SIK2 null mice. The mRNA levels
for Ppargc-1a and BDNF were higher in sik2/ mice than in
wild-type mice, whereas the mRNA levels of Trk-B in sik2/
mice were not significantly different compared to wild-type
mice (Figure 8D). The mRNA levels of CREB-independent genes
such as HSP70 and TGF-b were almost similar in sik2/ and
wild-type mice. However, the mRNA levels of the proinflamma-
tory cytokine TNF-a were significantly suppressed in sik2/
mice compared to wild-type mice after MCAO.
DISCUSSION
We presented evidence that SIK2 and the transcriptional coacti-
vator TORC1-CREB are important for neuronal survival after
ischemic injury (Figure 8E). We previously demonstrated that,
after exposure of cultured hippocampal neurons to glutamate,
the inhibition of CREB activity by a CRE-decoy oligonucleotide
or by the CaMK inhibitor KN93 resulted in a reduction in the
expression of the anti-apoptotic factor Bcl-2 (Mabuchi et al.,
2001). Thus, we hypothesized that CREB plays a pivotal role in
neuroprotection following ischemia-reperfusion. In fact, other
AC
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B Figure 7. SIK2 Deletion Enhances Neuronal
Survival after OGD via the Upregulation of
CREB Downstream Target Genes
(A) Cortical neurons from wild-type or sik2/
mice were cotransfected with adenovirus CRE
reporters. At 48 hr postinfection, cells were har-
vested for the luciferase assay after the indicated
periods following OGD.
(B) Cortical neurons fromwild-type or sik2/mice
were cotransfected with adeno-GAL4-fusion
TORC1 and the Adeno-5 3 GAL4-luciferase
reporter with the internal reporter Adeno-TK-rluc.
At 48 hr postinfection, cells were harvested for
the luciferase assay after the indicated periods
following OGD.
(C) SIK2 deficiency renders neurons more resis-
tant to OGD. Primary cortical cultures generated
from wild-type or sik2/ mice were exposed to
OGD, and the loss of MAP2 integrity (left) and the
level of neuronal injury at 24 hr were determined
using an LDH assay (right). Scale bar, 100 mm.
(D) Enhanced expression of CRE target genes in
cortical neurons from sik2/ mice. Cortical
neurons were cultured from wild-type or sik2/
mice. Neurons were transiently transfected with
the PGC-1a promoter 2 kb luciferase-adenovirus
(left panel), 400/+2 BDNF exon IV-luciferase-
adenovirus (center panel), or 1429/+2 Trk-B
(right panel), and ad-TK-rluc. At 48 hr postinfec-
tion, neurons were exposed to OGD, and a lucif-
erase assay was performed at 24 hr after OGD.
Error bars represent ± SD; +p < 0.05; ++p < 0.01.
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Role of SIK2-TORC1 in Neurotoxicitygroups have also demonstrated the involvement of CREB dysre-
gulation in a broad range of neurological diseases (Mantamadio-
tis et al., 2002; St-Pierre et al., 2006; Okamoto et al., 2009). In
particular the activation of the CREB–PGC-1a cascade may
contribute to neuronal cell survival in various neurological
diseases, including stroke, Huntington disease, and Parkinson
disease (Okamoto et al., 2009; St-Pierre et al., 2006).
Although other studies have implicated CREB, where phos-
phorylation at Ser133 in its kinase-inducible domain is often
equated with transcription of CREB target genes, Ser133 alone
is not sufficient to activate target genes containing CRE (Kita-
gawa, 2007; Lonze and Ginty, 2002; Mabuchi et al., 2001). In
fact the selective recruitment of CBP/p300 and perhaps other
coactivators may determine gene activation via the CREB bZIPNeuron 69, 106–119,domain (Schumacher et al., 2000).
Although a number of CREB target genes
for neuroprotection have been identified,
some discrepancies have also been
found in the transcriptional regulation of
these genes. The first discrepancy is
a difference in the temporal profiles
between the levels of CREB Ser133
phosphorylation and CRE activity and
the subsequent induction of putative
CREB target genes. In developing
cortical neurons, it has been recently re-
ported that CREB DNA binding is tightlycontrolled by extracellular stimuli such as neurotrophins, and
an NO-signaling pathway controls CREB binding independent
of CREB Ser133 phosphorylation (Riccio et al., 2006). These
findings suggest the existence of essential factors other than
phospho-Ser133 or its interacting molecules, i.e., CBP/p300,
that may share the same activation mechanism as phospho-
Ser133. We show here that, in cortical neurons, the dephosphor-
ylation of TORC1 and the subsequent nuclear import of TORC1
by Ca2+ led to the activation of CREB and its downstream target
genes.
Similar mechanisms have been studied in the gluconeogenic
program in the liver. For example, glucagon-cAMP signaling
promotes CREB-dependent gluconeogenic gene expression,
whereas insulin inhibits this promotion. Paradoxically, insulinJanuary 13, 2011 ª2011 Elsevier Inc. 115
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Figure 8. SIK2 Deficiency Attenuates
Lesion Size after MCAO
(A) The phosphorylation levels of TORC1 at Ser167
were examined in wild-type and sik2/ mice.
Brain lysates were obtained from the contralateral
and ipsilateral cerebral cortices of wild-type and
sik2/ mice at 24 hr after MCAO and reperfusion.
Western blot analysis was performed using anti-
bodies against phosphor-Ser167 TORC1, TORC1,
and SIK2.
(B) Wild-type and sik2/ mice were subjected to
transient MCAO for 60 min. Representative
sections stained by TTC are shown. Scale bar,
1 mm.
(C) Lesion volumes were quantified at 2 days after
MCAO in wild-type and sik2/ mice. The number
below each bar indicates the sample size (n = 7–8).
+p < 0.05 versus wild-type.
(D) Quantitative RT-PCR analysis of CREB-depen-
dent and CREB-independent gene expression in
wild-type and sik2/ mice. The mRNA levels of
CREB-dependent genes (BDNF, PGC-1a, Trk-B)
and CREB-independent genes (HSP70, TGF-b,
TNF-a) associated with ischemic brain injury
were examined in sham operation and ischemic
hemispheres at 8 and 24 hr after MCAO. The
results are expressed as the ratio of the ischemic
hemisphere to the hemisphere of sham operation
(n = 6). Error bars represent ± SD; +p < 0.05.
(E) Hypothetical model of the CaMK-mediated
regulation of the TORC1-CREB cascade via
SIK2. Intracellular Ca2+ in neurons after ischemia
enhances the activity of CaMKs via the NR2A-con-
taining NMDAR. Activated CaMK I/IV phosphory-
lates SIK2 at Thr484 followed by SIK2 degrada-
tion. The ischemia-induced degradation of SIK2
dephosphorylates TORC1 at Ser167, leading to
its translocation into the nucleus. Then, TORC1
induces CREB target genes, such as Ppargc-1a
and Bdnf, and leads to neuronal protection after
ischemia.
Neuron
Role of SIK2-TORC1 in Neurotoxicitysignaling can also phosphorylate CREB at Ser133. The paradox
between the level of phospho-Ser133 and CREB activity in the
gluconeogenic program can be explained by the coactivator
TORC2 (Dentin et al., 2007; Koo et al., 2005). When cAMP
cascades are initiated, PKA inactivates SIKs and activates
a TORC phosphatase, likely calcineurin, inducing the nuclear
import of TORC2 followed by its binding to CREB (Screaton
et al., 2004). The activation of TORC2 occurs concomitantly
with the phosphorylation of CREB at Ser133 because these
two factors are regulated by a common upstreammolecule PKA.
NMDARs constitute a major class of ionotropic glutamate
receptors and play a key role in CNS physiology and pathophys-
iology. Functional NMDARs are heteromultimers formed by the
assembly of the obligate NR1 plus either NR2A or NR2B or
a mixture of the two. In particular, synaptic NR2A- and extrasy-
naptic NR2B-containing NMDARs have opposite effects on
CREB function, gene regulation, and neuron survival (Hardi-116 Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc.ngham et al., 2002; Liu et al., 2007). In this study we showed
that Ca2+ signals, via NR2A-containing NMDARs or synaptic
activity, e.g. Bic and 4-AP, activate TORC-mediated transcrip-
tion mediated by the CaMK I/IV-SIK2 cascade. SIK2 was
degraded via the proteasome following phosphorylation at Thr
484 by CaMK I/IV, but not CaMK II, leading to CREB-dependent
neuroprotective gene expression. In addition, CaMK IV can also
phosphorylate CBP and thereby stimulate CREB-dependent
transcription (Hardingham et al., 1999; Impey et al., 2002).
Collectively, these findings indicate that CaMK IV may govern
distinct neuronal survival pathways with Ca2+-dependent cross-
talk between them, and converge on CREB-CRE signaling and
their downstream targets. Similarly, PKA inactivates the TORC-
kinase activity of SIK2 by phosphorylating it at Ser587. Although
Thr484 and Ser587 are located in a region that is highly
conserved from insects to humans, the mechanism by which
phospho-Ser587 inactivates SIK2 may be different from that of
Neuron
Role of SIK2-TORC1 in Neurotoxicityphospho-Thr484 because Ser587 phosphorylation does not
induce SIK2 degradation (Katoh et al., 2006). This evidence
suggests the possibility that Ca2+ activates TORC1 via the phos-
phorylation of SIK2 at Thr484, whereas cAMP activates TORC1
via the phosphorylation of SIK2 at Ser587. Both pathways are
accompanied by the phosphorylation of CREB at Ser133. This
is the reason why phospho-CREB Ser 133 is recognized as
representative of the induction of CREB-dependent gene
expression.
Consistent with previous reports, mammalian neurons in the
CNS predominantly express TORC1 (Zhou et al., 2006), and
low levels of TORC2 protein are also detected in neurons (Lerner
et al., 2009). A recent study using Drosophila showed that the
loss of TORC1 resulted in the enhancement of lethality with star-
vation and oxidative stress induced by paraquat (Wang et al.,
2008). In contrast, Drosophila expressing RNAi for SIK2 acquires
resistance to the above stresses (Wang et al., 2008). Moreover,
Caenorhabditis elegans with a Kin-29 loss-of-function mutation,
the ortholog of SIK, has increased longevity with a smaller body
size (van der Linden et al., 2007). In order to gain further insight
into the role of SIK2, we generated sik2/ mice. These mutant
mice are fully viable, have intact brain anatomy, and appear to
develop normally. Under conditions of SIK2 knockdown using
micro-SIK2 RNAi, the additive neuroprotective effects of
concomitant TORC1 overexpression were no longer observed
(Figure 3H). On the other hand, DN-TORC1 blunted SIK2 down-
regulation-induced neuronal protection (Figure 3H). Importantly,
we observed enhanced neuroprotection after in vivo ischemia in
sik2/mice and upregulation of CREB-dependent gene expres-
sion in sik2/ mice. These findings suggested that SIK2 knock-
down contributed to neuronal protection primarily through
TORC1-CREB-dependent neuronal survival, but the change in
expression of CREB-independent factors such as inflammatory
cytokine TNF-a might be involved in the neuroprotection
observed in sik2/ mice, suggesting a broad range of SIK2
function in neuronal protection.
In summary we identified that SIK2-TORC1 in the CREB-
signaling pathway regulates the survival of cortical neurons after
brain ischemia. The results presented in the present study
suggest that the SIK2-TORC1-CREB signaling pathway may
serve as a potential therapeutic target for promoting the survival
of neurons. These findings also raise new opportunities for the
development of novel therapeutics.
EXPERIMENTAL PROCEDURES
A detailed description of all procedures is included in the Supplemental Exper-
imental Procedures.
Antibodies
The following primary antibodies were used for immunofluorescence, immu-
noprecipitation, and immunoblots analysis: mouse monoclonal anti-MAP2
(Sigma), rabbit polyclonal anti-phospho-CREB (pCREB) (Upstate Biotech-
nology), rabbit polyclonal anti-CREB (Upstate, Bio) rabbit anti-phospho-
AMPK (pAMPK) (NEB), and rabbit anti-AMPK (NEB).
TORC1 antisera were raised against human TORC1 (551–650) and TORC3
(480–619) peptides. As these antisera cross-reacted with TORC1 and
TORC3, the IgG was purified from the anti-TORC1 serum using the TORC3
peptide. The resultant anti-TORC1/3 IgG could recognize TORC1 and
TORC3 with equal efficiency. The phospho-TORC1 (Ser167), phospho-SIK2(Thr484), phospho-SIK2 (Ser578), and anti-SIK1 antibodies were produced
in our laboratory.
Primary Cortical Cultures
Primary cultures of rat cortical neurons were obtained as described previously
(Mabuchi et al., 2001). In brief, neuronal cultures were prepared from the
cortex of embryonic day 16 (E16) rat embryos. Cells were used after
10–11 days in vitro when most cells showed a neuronal phenotype. See
Supplemental Experimental Procedures for details.
Construction of miRNA against SIK2 and CaMK IV and the
Preparation of Recombinant Adenoviruses
miRNA (miRNAi) oligonucleotides and complementary strands were designed
to target the consensus sequence of rat SIK2 and CaMK IV. To obtain the
knockdown of SIK2 and CaMK IV in cortical neurons, we constructed miRNA
cassettes in an expression plasmid. A BsaI linker (50-TGCTGGAGACCT
TATGGTCTCA/50-CCTGTGAGACCATAAGGTCTCC; the underlined sections
show the recognition sites) was ligated into the cloning site of the
pcDNA6.2-GW/miR vector (Invitrogen). The region containing a GFP tag and
the BsaI-cloning site was transferred to the pDONR221 vector by means of
BP-Clonase, and the resultant vector was named pDONR-GW/miR. Oligonu-
cleotides for miRNA against rat SIK2 mRNA (see Supplemental Experimental
Procedures) were annealed and ligated to the BsaI site of pDONR-GW/miR.
In contrast, oligonucleotides for miRNA against rat CaMK IV miRNA-1, -2, -3,
and -4 (see Supplemental Experimental Procedures) were ligated into the
cloning site of the pcDNA6.2-GW/miR vector (Invitrogen). Although CaMK IV
miRNA-1, -2, -3, and -4 each modestly attenuated (by 40%) CaMK IV expres-
sion (data not shown), chaining of these CaMK IV miRNA-1, -2, -3, and -4 to
the same vector more effectively attenuated CaMK IV protein expression.
The region containing the GFP tag and miRNA was then transferred to the
Gateway-based pAd-CMV/DEST vector (Invitrogen) using the LR reaction
according to the manufacturer’s instructions. Primary cortical neurons were
transfected with adeno-miRNAs. The efficacy of SIK2 miRNA or CaMK IV
miRNA-1/2/3/4 was evaluated using western blot analysis at 4–5 days after
the transduction of primary cortical neurons, which express endogenous
SIK2 or CaMK4, with serial dilutions of concentrated miRNA. At 4 days post-
infection, the cells were harvested for the luciferase assay and an LDH assay
after OGD.
Dual-Glo Luciferase Assay
Primary cortical neurons were infected with the purified adenovirus (adeno-
CRE-Luc [firefly] and adeno-TK-Luc [renilla]). The adenovirus containing
a CMV promoter driving renilla luciferase was used as an internal control
(Promega) as previously described (Katoh et al., 2006).
Immunohistochemistry
Primary cortical neurons were fixed immediately with 4% PFA for 30 min. For
double-immunofluorescence in vivo, free-floating sections (40 mm) were used.
See Supplemental Experimental Procedures for details.
In Vitro Phosphorylation of SIK2 by CaMKs
To prepare an SIK2-Thr484 peptide, a set of oligonucleotides for the SIK2
peptide (Gly479 to Thr489: 50-gatcGGGCAGCGACGGCACACTCTGTCAG
AAGTGACT and 50-aattAGTCACTTCTGACAGAGTGTGCCGTCGCTGCCC)
was cloned into the BamHI/EcoRI site of the Escherichia coli GST-fusion
vector pGEX6P-1, and the GST-SIK2 (Thr484) peptide was purified by using
a glutathione-Sepharose column. To prepare active CaMKs, cDNA fragments
for constitutive active CaMKs were ligated into the BamH1/NotI site of pEBG
mammalian GST-fusion vector, and the active CaMKs were expressed in
COS-7 cells followed by purification with a glutathione-Sepharose column.
The GST-SIK2 (Thr484) peptide (1 mg) was incubated with CaMKs in a reaction
buffer (10 mM Tris-HCl [pH 7.4], 10 mM MgCl2, in the presence or absence of
100 mM ATP) at room temperature for 1 hr, and phospho-SIK2 (Thr484) was
detected by western blot analyses with anti-phospho-Thr484 antiserum.
Immunoprecipitation and Immunoblots
These were performed as previously described (Katoh et al., 2006) (see
Supplemental Experimental Procedures). Data are representative of at least
four independent experiments.Neuron 69, 106–119, January 13, 2011 ª2011 Elsevier Inc. 117
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Role of SIK2-TORC1 in NeurotoxicityQuantitative Real-Time PCR Analysis
Total RNA was extracted by using TRIzol (Invitrogen). cDNAs were prepared
by reverse transcription (RT) from total RNA (1 mg) by using SuperScript III
and random primers (Invitrogen). One-hundredth of the RT products and stan-
dard plasmids were subjected to real-time PCR analyses with the iQ SYBR
Green Supermix (Invitrogen) or TaqMan Probe Universal PCR Master Mix
(Applied Biosystems). The specific primers used are listed in Table S1. See
Supplemental Experimental Procedures for details.
Generation of Sik2–/– Mice
The generation of Sik2+/ mice has been described by Horike et al. (2010);
these mice are now supplied by JCRB Laboratory Animal Resource Bank at
the National Institute of Biomedical Innovation (NIBIO) No. nbio071; http://
animal.nibio.go.jp/index.html. Although Sik2+/ ES cells were established in
C57BL/6-derived cells (RENKA), Sik2+/ mice were mated with C57BL/6J
mice for ten generations; then, mouse colonies were amplified for the experi-
ments. The experimental protocols using mice were approved by committees
at the NIBO. The animals were maintained under standard conditions of light
(8:00 a.m.–8:00 p.m.) and temperature (23C, 40% humidity).
OGD
OGD was performed by placing cultures in a 37C incubator housed in an
anaerobic chamber. See Supplemental Experimental Procedures for details.
Cell Viability Assays
Neuronal injury wasmeasured at 24 hr after OGD for 3 hr with lactate dehydro-
genase (LDH) using the Cytotoxicity Detection Kit (Roche Applied Science).
When we examined the effect of DN-TORC1 transfection and CaMK
IV-specific miRNA on neuronal survival, cultured neurons were exposed to
OGD for 2 hr, followed by reoxygenation. In a sister culture, 100% cell death
was induced using 2 mmol/l NMDA. The relative assessments of neuronal
injury were normalized by comparison with 100% cell death.
Transient Focal Ischemia
The right-middle cerebral artery was occluded for 60 min using a suture and
then reperfused. As described previously (Kitagawa et al., 1998), only mice
with less than 30% of the baseline control microperfusion during the first
minute of occlusion were used in subsequent experiments. See Supplemental
Experimental Procedures for details.
Statistical Analysis
All results are reported as the mean ± standard deviation (SD), and analyses
were performed using SPSS software. Three experimental groups were
compared using the Kruskal-Wallis test or one-way analysis of variance
(ANOVA) with Scheffe’s post hoc pairwise analyses. Two experimental groups
were compared with Student’s unpaired two-tailed t test. Statistical signifi-
cance was defined as p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and eight figures and can be found with this article online at doi:10.1016/
j.neuron.2010.12.004.
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